Benefits of cystic fibrosis drug ivacaftor reported in pre-school children for the first time
The oral drug ivacaftor appears to be safe and could be beneficial to young children between the ages of 2 and 5 with a specific type of cystic fibrosis, according to new research published in The Lancet Respiratory Medicine ...
Jan 21, 2016